Madrigal Pharmaceuticals, Inc. (MDGL)
523.69
-16.20
(-3.00%)
USD |
NASDAQ |
May 15, 16:00
524.10
+0.41
(+0.08%)
After-Hours: 20:00
Madrigal Pharmaceuticals Profit Margin (Quarterly) : -30.32% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Insmed, Inc. | -53.46% |
| ACADIA Pharmaceuticals, Inc. | 1.36% |
| PTC Therapeutics, Inc. | -1.03% |
| Protagonist Therapeutics, Inc. | 6.71% |
| Altimmune, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.68% |
| Return on Assets | -26.40% |
| Return on Invested Capital | -34.66% |
| Gross Profit Margin (Quarterly) | 91.25% |
| Operating Margin (Quarterly) | -29.78% |
| Return on Net Operating Assets | -151.3% |